Acute respiratory distress syndrome (ARDS) is a life-threatening, acute, diffuse, inflammatory form of lung damage characterized by low oxygenation, pulmonary infiltrates, and acuity of onset. ARDS is defined as an acute illness that manifests as bilateral lung infiltrates and severe progressive hypoxemia in the absence of cardiogenic pulmonary edema within 7 days after the initial event.
Patients with ARDS typically have various degrees of pulmonary artery vasoconstriction and may eventually develop pulmonary hypertension. ARDS has a significant fatality rate, and there are few effective therapeutic options available to combat it.
There are numerous risk factors for ARDS. Extra-pulmonary causes include sepsis, trauma, major transfusion, drowning, drug overdose, fat embolism, inhalation of toxic gases, and pancreatitis, in addition to pulmonary infection or aspiration. These extra-thoracic infections and/or injuries set off an inflammatory cascade that leads to pulmonary damage.
The lung injury prevention score aids in the identification of low-risk patients, although a high score is less useful.
The prevalence of ARDS in the United States is estimated to be 64.2 to 78.9 cases per 100,000 people. 25% of ARDS cases are primarily classed as mild, whereas 75% are classified as moderate or severe. However, one-third of mild cases advance to moderate to severe disease.
An analysis of the literature indicated a 1.1% annual decrease in mortality from 1994 to 2006. The overall pooled death rate for all studies reviewed, however, was 43%. ARDS mortality is proportional to illness severity; it is 27%, 32%, and 45% for mild, moderate, and severe diseases, respectively.
The severity of ARDS symptoms depends on the etiology and severity of the condition. They include -
The physical exam, chest X-ray, and oxygen levels are used to make the diagnosis. It's also critical to rule out other diseases and ailments that can cause similar symptoms, such as certain cardiac problems. These include -
Imaging
Lab Tests
Your oxygen level can be measured using blood drawn from an artery in your wrist. If your doctor suspects you have a lung infection, secretions from your airway may be analyzed to discover the cause.
Heart Tests
Treatment for ARDS typically focuses on improving blood oxygen levels, giving breathing assistance, and addressing the disease's underlying cause.
Oxygen
Medication
ARDS medication work by -
Read more such content on Hidoc Dr | Medical Learning App for Doctors
1.
Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca
2.
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer
3.
Asymptomatic Brain Metastases in EGFR-Mutant NSCLC
4.
Mapping lifelong chronic health risks for childhood cancer survivors
5.
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC
1.
Respiratory Ramifications of Systemic Disease: A Comprehensive Review
2.
Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery
3.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
4.
Cancer Care Advances: Metformin, Digital Tools, and Artificial Renal Support
5.
Molecular Mechanisms, Clinical Efficacy, and Stem Cell Therapy Integration in Leukemia Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation